Royal Bank of Canada’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-85
| Closed | – | – | 7376 |
|
|
2023
Q1 | $0 | Hold |
85
| – | – | ﹤0.01% | 7135 |
|
|
2022
Q4 | $0 | Hold |
85
| – | – | ﹤0.01% | 7438 |
|
|
2022
Q3 | $0 | Sell |
85
-58
| -41% | – | ﹤0.01% | 7523 |
|
|
2022
Q2 | $0 | Sell |
143
-1,816
| -93% | – | ﹤0.01% | 7396 |
|
|
2022
Q1 | $5K | Sell |
1,959
-4,666
| -70% | -$11.9K | ﹤0.01% | 6797 |
|
|
2021
Q4 | $31K | Buy |
6,625
+3,523
| +114% | +$16.5K | ﹤0.01% | 6082 |
|
|
2021
Q3 | $27K | Buy |
3,102
+849
| +38% | +$7.39K | ﹤0.01% | 6006 |
|
|
2021
Q2 | $36K | Sell |
2,253
-30
| -1% | -$479 | ﹤0.01% | 5752 |
|
|
2021
Q1 | $51K | Buy |
2,283
+1,576
| +223% | +$35.2K | ﹤0.01% | 5379 |
|
|
2020
Q4 | $22K | Buy |
707
+676
| +2,181% | +$21K | ﹤0.01% | 5473 |
|
|
2020
Q3 | $1K | Buy |
31
+7
| +29% | +$226 | ﹤0.01% | 6024 |
|
|
2020
Q2 | $0 | Sell |
24
-252
| -91% | – | ﹤0.01% | 6433 |
|
|
2020
Q1 | $2K | Sell |
276
-798
| -74% | -$5.78K | ﹤0.01% | 5852 |
|
|
2019
Q4 | $15K | Buy |
1,074
+1,018
| +1,818% | +$14.2K | ﹤0.01% | 5398 |
|
|
2019
Q3 | $1K | Buy |
+56
| New | +$1K | ﹤0.01% | 5881 |
|